BioCentury
ARTICLE | Financial News

Cardioxyl raises $28.1M in B round

November 9, 2012 1:41 AM UTC

Cardioxyl Pharmaceuticals Inc. (Chapel Hill, N.C.) raised $28.1 million in a series B round led by new investor Orbimed Advisors. New investor Osage University and existing investors New Enterprise As...